Varian Biopharmaceuticals to go public through merger with SPAC SPK Acquisition
Varian Biopharmaceuticals plans to go public through a merger with SPAC SPK Acquisition Corp (NASDAQ:SPK). The combined company's post-transaction equity value is expected to be around $116M. The dea
SPK Acquisition Enters Deal to Merge With Varian Biopharmaceuticals
09:51 AM EST, 02/14/2022 (MT Newswires) -- SPK Acquisition Corp. (SPK) said Monday it has agreed to merge with privately owned Varian Biopharmaceuticals to create a combined company with an expected
SPK Acquisition in Deal to Take Varian Bio Public
By Chris Wack SPK Acquisition Corp. on Monday said it was in a deal to make Varian Biopharmaceuticals Inc. a publicly traded company. The special purpose acquisition company said Varian B
News On SPK Acquisition Corp. (SPKAU) Now Under SPK
*DJ News On SPK Acquisition Corp. (SPKAU) Now Under SPK (END) Dow Jones Newswires July 23, 2021 17:08 ET (21:08 GMT) Copyright (c) 2021 Dow Jones & Company, Inc.